BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27367024)

  • 1. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
    Wu CS; Chang KP; OuYang CN; Kao HK; Hsueh C; Chen LC; Cheng HY; Liang Y; Liou W; Liang CL; Chang YS
    Oncotarget; 2016 Aug; 7(31):50074-50085. PubMed ID: 27367024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
    BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
    Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
    Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
    Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
    J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Vimentin Expression Associated with Lymph Node Metastasis and Predicated a Poor Prognosis in Oral Squamous Cell Carcinoma.
    Liu S; Liu L; Ye W; Ye D; Wang T; Guo W; Liao Y; Xu D; Song H; Zhang L; Zhu H; Deng J; Zhang Z
    Sci Rep; 2016 Dec; 6():38834. PubMed ID: 27966589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.
    Zeng Y; Zheng J; Zhao J; Jia PR; Yang Y; Yang GJ; Ma JF; Gu YQ; Xu J
    Tumour Biol; 2016 May; 37(5):6719-28. PubMed ID: 26662107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
    BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
    Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
    PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASC modulates HIF-1α stability and induces cell mobility in OSCC.
    Wu CS; Chang IY; Hung JL; Liao WC; Lai YR; Chang KP; Li HP; Chang YS
    Cell Death Dis; 2020 Sep; 11(9):721. PubMed ID: 32883954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
    Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
    Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
    Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
    Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
    Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
    World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.